British biopharmaceutical company Grow Group PLC announces GBP 6 million Series C fundraise for cannabis market expansion


Ryan Allway

November 16th, 2020

News, Top News



LONDONNov. 12, 2020 /PRNewswire/ — Medical cannabis biopharma leader Grow launches GBP 6 million Series C fundraise to scale-up existing UK operations and accelerate expansion across Europe.

  • Grow seeks to accelerate towards its goal of being the world’s leading supplier of medical cannabis by patient numbers by 2025
  • UK taxpayers investing into Grow equity should benefit from Enterprise Investment Scheme (“EIS”) tax benefits
  • Open to Sophisticated and High Net Worth investors only
  • Recent FCA announcement that UK licensed medical cannabis companies should be able to list on a UK stock exchange, provides medium term exit potential.

Today Grow launched its Series C fundraise to finance the expansion of the company’s highly successful business model across Europe. Grow has developed a unique and synergistic combination of integrated operations across medical cannabis distribution, education, biotechnological R&D, and international trading. Grow is now seeking to expand its domestic operations as well as its international presence.

The European medical cannabis market is expected to be worth $3.3bn and the global medical cannabis opportunity worth $14.4bn by 2024 and is on a fast growth trajectory as more and more markets introduce legal medical cannabis regulations.

Grow will be offering the opportunity to invest in their Series C round to high net worth and sophisticated investors only, across individuals, funds, potential corporate-trade investors, and family offices.

Ben Langley, the CEO of Grow, who was recently listed in the top 100 UK entrepreneurs by the Daily Telegraph and the top 10 in the Healthcare category said,
“We’ve been fortunate to enjoy fantastic support in the past from shareholders who genuinely believe that our laser focus on patient wellbeing will drive ethical commercial success. We look forward to welcoming new shareholders to the Grow family at this hugely exciting time for Grow, for the industry, and, most importantly, for patients globally.”

Dean Gainsley, Non-Executive Director of Grow and cannabis industry advisor said
“The recent FCA guidance to allow UK licensed medical cannabis companies to list on UK exchanges has finally provided investors the necessary clarity to feel confident in backing this exciting and fast moving industry. Coupled with the huge growth of the medical cannabis market around the world, this Series-C raise provides an exceptional window of opportunity to participate in the success of the UKs leading medical cannabis business”.

For more information visit www.growgrouplc.com or contact: [email protected]

About Grow
Grow Group PLC (“Grow”) is a biopharmaceutical company focused solely on cannabis based medicines and improving global patient access to those medicines. The company distributes, innovates and solves fundamental industry issues in order to bring affordable pharma-quality cannabis medicines to patients globally. Grow empowers and educates doctors to make the correct medical cannabis prescribing decisions.

Grow Group consists of the following divisions:

Grow Pharma – A joint venture with IPS Pharma. Leader in the distribution of cannabis medicines in the UK and Ireland as well as the education of healthcare professionals.

Grow Trading – The world’s first medical cannabis trading company, providing solutions to the industry to develop an uninterrupted supply chain for the ultimate benefit of patients.

Grow Biotech – R&D division focused on developing new technologies to bring down the cost of manufacturing and increasing the quality of medicines.

SOURCE Grow Group PLC

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading